+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 10Years - 17Years
All Genders
ID05889624

Comparing Telehealth Cognitive Behavioral Therapy With and Without Amitriptyline for Preventing Pediatric Migraine

Led by Children's Hospital Medical Center, Cincinnati · Updated on 2026-09-21

400

Participants Needed

15

Research Sites

21 weeks

Total Duration

AI-Summary

What This Trial Is About

This research aims to compare two first-line preventive treatments for youth with migraine to help neurologists, psychologists, and primary care providers improve care based on real-world experiences. It focuses on testing the feasibility of delivering Cognitive Behavioral Therapy CBT through telehealth, with or without the addition of a clinically prescribed pill-based medication called amitriptyline. Migraine is a disabling condition affecting around 10% of children and adolescents, making it important to find effective ways to reduce its impact early in life. Participants will be randomly assigned to one of two groups one group will receive six telehealth CBT sessions while taking daily amitriptyline medication, with doses gradually increased over eight weeks and maintained for sixteen weeks. The other group will receive only six telehealth CBT sessions without medication. Both groups will then attend three booster CBT sessions over four months. CBT sessions include education on pain, behavioral techniques like muscle relaxation, and cognitive strategies such as problem solving and calming self-statements, with some sessions involving a parent or guardian. Participants will be involved for approximately 28 weeks, starting with 4 weeks of baseline observation, followed by 8 weeks of active treatment, and then a 16-week maintenance phase. During study visits, researchers will collect headache diaries, disability questionnaires, and safety assessments related to CBT and amitriptyline. The main outcomes measured are changes in the number of headache days and reduction in headache-related disability. Safety and tolerability of the treatments will also be monitored throughout the study.

CONDITIONS

Brief Title

Responding With Evidence and Access for Childhood Headaches

Research Team

L

LeighAnn Chamberlin, MEd

M

Megan Pfeiffer

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here